6-K

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C.  20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2020

Commission File No. 001-38885

ORGANIGRAM HOLDINGS INC.
(Translation of registrant's name into English)

35 English Drive
Moncton, New Brunswick, Canada E1E 3X3

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40‑F

Form 20-F  [  ]  Form 40-F  [X]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  [  ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  [  ]

SUBMITTED HEREWITH

Exhibits
99.1	Press Release dated February 25, 2020
99.2	Report of Voting Results dated February 25, 2020

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ORGANIGRAM HOLDINGS INC.

“Paolo De Luca”
______________________________________
Paolo De Luca
Chief Financial Officer

Date:  February 25, 2020

EX-99.1

Exhibit 99.1

Organigram Holdings Inc. Announces Election of Directors

MONCTON, New Brunswick--(BUSINESS WIRE)--February 25, 2020--Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today that each of the eight nominees listed in its management information circular dated January 23, 2020 (the “Circular”) was elected as a director of Organigram at the Annual and Special Meeting of Shareholders (the “Meeting”) held on February 25, 2020. The vote was conducted by a show of hands. Detailed results of the votes cast by proxy are set out below:

Nominee	Votes For	% of Votes For	Votes Withheld	% of Votes Withheld
Peter Amirault	16,616,184	97.12	492,516	2.88
Greg Engel	16,625,303	97.18	483,397	2.83
Dexter John	16,078,699	93.98	1,030,001	6.02
Geoffrey Machum	16,611,530	97.09	497,170	2.91
Ken Manget	16,654,923	97.35	453,777	2.65
Sherry Porter	16,319,053	95.39	789,647	4.62
Stephen Smith	16,642,629	97.28	466,071	2.72
Derrick West	16,600,454	97.03	508,246	2.97

The biographies of the Corporation’s directors are set out in the Circular, which is available under the Corporation’s profile on SEDAR at www.sedar.com.

“On behalf of the board, I am delighted to welcome Geoffrey, Ken and Stephen to our team. They bring a robust set of knowledge, skills and experience, and they will complement our board as we continue to grow in a dynamic industry,” said Greg Engel, Organigram’s Chief Executive Officer. “We would also like to thank Mike Bourque, who did not stand for re-election, for his valuable contributions and service to the board over the past few years.”

Following the Meeting, the newly-elected board of directors of the Corporation (the “Board”) re-appointed Peter Amirault as Chairman of the Board. The Board also re-constituted its committees as follows:

• Audit Committee: Stephen Smith (Chair), Dexter John, Ken Manget, and Derrick West
• Governance and Nominating Committee: Geoffrey Machum (Chair), Sherry Porter, and Dexter John
• Compensation Committee: Sherry Porter (Chair), Geoffrey Machum, and Ken Manget
• Investment Committee: Dexter John (Chair), Ken Manget and Stephen Smith

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Contacts

For Investor Relations enquiries, please contact:
Amy Schwalm
Vice President, Investor Relations
Amy.Schwalm@organigram.ca
(416) 704-9057

For Media enquiries, please contact:
Ray Gracewood
Senior Vice President, Marketing and Communications
ray.gracewood@organigram.ca
(506) 645-1653

EX-99.2

Exhibit 99.2

ORGANIGRAM HOLDINGS INC.
(the “Corporation”)

Annual and Special Meeting of Shareholders
Held on February 25, 2020

REPORT OF VOTING RESULTS

Pursuant to section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, this report describes the matters decided at the 2020 Annual and Special Meeting of Shareholders of the Corporation held on February 25, 2020. Full details of the matters are set out in the Corporation’s management information circular dated January 23, 2020, which is available on SEDAR at www.sedar.com.

1. ELECTION OF DIRECTORS

Each of the following individuals were elected as directors of the Corporation as approved by a vote by show of hands, for a term expiring at the conclusion of the next annual meeting of shareholders of the Corporation, or until their successors are elected or appointed. According to the final scrutineer report prepared following the meeting (“Final Scrutineer Report”), the voting results were as follows:

Nominee	Votes For	% of Votes For	Votes Withheld	% of Votes Withheld
Peter Amirault	16,616,184	97.12	492,516	2.88
Greg Engel	16,625,303	97.18	483,397	2.83
Dexter John	16,078,699	93.98	1,030,001	6.02
Geoffrey Machum	16,611,530	97.09	497,170	2.91
Ken Manget	16,654,923	97.35	453,777	2.65
Sherry Porter	16,319,053	95.39	789,647	4.62
Stephen Smith	16,642,629	97.28	466,071	2.72
Derrick West	16,600,454	97.03	508,246	2.97

2. APPOINTMENT OF AUDITOR

By a resolution passed by a vote by show of hands, Deloitte LLP was reappointed as the auditor of the Corporation until the next annual meeting of the shareholders of the Corporation or until its successor is appointed and the directors of the Corporation were authorized to fix the remuneration of such auditor. According to the Final Scrutineer Report, the voting results were as follows:

# Votes For	% Votes For	# Votes Withheld	% Votes Withheld
63,060,605	98.28	1,106,732	1.73

3. APPROVAL OF ARTICLES OF AMENDMENT

By a resolution passed by a ballot vote, the articles of amendment approved by the board of directors of the Corporation on January 23, 2020, were approved. According to the Final Scrutineer Report, the voting results were as follows:

# Votes For	% Votes For	# Votes Against	% Votes Against
16,053,666	93.83	1,055,034	6.17

4. CONFIRMATION OF AMENDED AND RESTATED BY-LAW NO. 1

By a resolution passed by a ballot vote, the Amended and Restated By-Law No. 1 adopted by the board of directors of the Corporation on January 23, 2020, was confirmed. According to the Final Scrutineer Report, the voting results were as follows:

# Votes For	% Votes For	# Votes Against	% Votes Against
14,235,160	83.20	2,873,540	16.80

5. APPROVAL OF OMNIBUS EQUITY INCENTIVE PLAN

By a resolution passed by a ballot vote, the Omnibus Equity Incentive Plan adopted by the board of directors of the Corporation on January 23, 2020, was approved. According to the Final Scrutineer Report, the voting results were as follows:

# Votes For	% Votes For	# Votes Against	% Votes Against
11,856,772	69.30	5,251,928	30.70